Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval
Back around 2005, in a pharmaceutical research lab in Nutley, N.J., Becky Taub noticed something. She and other scientists at Roche ROG, -0.34% were studying a molecule to see if it had potential as a treatment for diabetes or obesity. What Taub discovered was that the therapy, now called resmetirom, was instead removing fat from…